Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: other routes

Currently viewing:

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
migrated information: read-across based on grouping of substances (category approach)
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Summary table with LD50 values from literature.

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
No information
Author:
RTECS
Year:
1909
Bibliographic source:
Journal of Pharmacology and Experimental Therapeutics (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Reference Type:
publication
Title:
No information
Author:
RTECS
Year:
1951
Bibliographic source:
Japanese Journal of Pharmacology (Japanese Pharmacological Soc., c/o Dept. of Pharmacology, Faculty of Medicine, Kyoto Univ., Sakyo-ku, Kyoto 606, Japan) V.1- 1951
Reference Type:
publication
Title:
No information
Author:
RTECS
Year:
1940
Bibliographic source:
Journal of the American Pharmaceutical Association, Scientific Edition (Washington, DC) V.29-49, 1940-60
Reference Type:
publication
Title:
No information
Author:
RTECS
Year:
1925
Bibliographic source:
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie (Berlin, Ger.) V.110-253, 1925-66.

Materials and methods

Test material

Constituent 1
Reference substance name:
Sodium thiocyanate
EC Number:
208-754-4
EC Name:
Sodium thiocyanate
Cas Number:
540-72-7
IUPAC Name:
sodium thiocyanate

Results and discussion

Any other information on results incl. tables

Route  

Organism

Dose  

Reference

intraperitoneal  

rat

LD50 540 mg/kg   

Journal of Pharmacology and Experimental Therapeutics   (Williams & Wilkins Co., , , )  V.1-    1909/10-

intraperitoneal

mouse

LD50 500 mg/kg    

Japanese Journal of Pharmacology   (Japanese Pharmacological Soc., c/o Dept. of Pharmacology, Faculty of Medicine, , Sakyo-ku, Kyoto 606, Japan)  V.1-    1951

subcutaneous

mouse

LDLo 400 mg/kg   

Journal of the American Pharmaceutical Association, Scientific Edition (, ) V.29-49, 1940-60.

intravenous  

mouse 

LD50 484 mg/kg   

Journal of the American Pharmaceutical Association, Scientific Edition (, ) V.29-49, 1940-60.

intravenous

dog

LDLo 100 mg/kg

Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie   (, ) V.110-253, 1925-66. 

subcutaneous

rabbit

LDLo 200 mg/kg

Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie   (, ) V.110-253, 1925-66. 

intravenous

rabbit

LDLo 100 mg/kg

Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie   (, ) V.110-253, 1925-66. 

Intraperitoneal

guinea pig

LDLo 500 mg/kg

Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie   (, ) V.110-253, 1925-66. 

Subcutaneous

guinea pig

LDLo 500 mg/kg

Journal of the American Pharmaceutical  Association, Scientific Edition (, ) V.29-49, 1940-60.

Applicant's summary and conclusion

Conclusions:
The reported acute toxicity via other routes for sodium thiocyanate in RTECS shows an LD50 via i.p. of 500 in mice, 540 in rat, and 500 mg/kg in guinea pig. Further LDlo values reported involving subcutaneous and intravenous dosing in various species range between 100 and 484 mg/kg.
Executive summary:

Summary table with acute toxicity values via other routes from RTECS for sodium thiocyanate.

 

Route

Organism

Dose

Reference

intraperitoneal

rat

LD50 540 mg/kg

Journal of Pharmacology and Experimental Therapeutics (Williams & Wilkins Co., , , ) V.1- 1909/10 -

intraperitoneal

mouse

LD50 500 mg/kg

Japanese Journal of Pharmacology (Japanese Pharmacological Soc., c/o Dept. of Pharmacology, Faculty of Medicine, , Sakyo-ku, Kyoto 606, Japan) V.1- 1951

subcutaneous

mouse

LDLo 400 mg/kg

Journal of the American Pharmaceutical Association, Scientific Edition (, ) V.29-49, 1940-60.

intravenous

mouse

LD50 484 mg/kg

Journal of the American Pharmaceutical Association, Scientific Edition (, ) V.29-49, 1940-60.

intravenous

dog

LDLo 100 mg/kg

Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie (, ) V.110-253, 1925-66.

subcutaneous

rabbit

LDLo 200 mg/kg

Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie (, ) V.110-253, 1925-66.

intravenous

rabbit

LDLo 100 mg/kg

Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie (, ) V.110-253, 1925-66.

Intraperitoneal

guinea pig

LDLo 500 mg/kg

Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie (, ) V.110-253, 1925-66.

Subcutaneous

guinea pig

LDLo 500 mg/kg

Journal of the American Pharmaceutical Association, Scientific Edition (, ) V.29-49, 1940-60.